Alhallak, Kinan
Sun, Jennifer
Wasden, Katherine
Guenthner, Nicole http://orcid.org/0000-0001-5730-4775
O’Neal, Julie
Muz, Barbara
King, Justin
Kohnen, Daniel
Vij, Ravi
Achilefu, Samuel http://orcid.org/0000-0002-3133-6717
DiPersio, John F.
Azab, Abdel Kareem http://orcid.org/0000-0002-6371-2780
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (TL1TR002344)
Foundation for the National Institutes of Health (U54CA199092)
Article History
Received: 27 July 2020
Revised: 1 December 2020
Accepted: 7 January 2021
First Online: 21 January 2021
Compliance with ethical standards
:
: AKA and KA have filed a patent with regards to the technology described in this study. AKA is the founder and owner of Cellatrix LLC and some of the experiments were performed using products supplied by Cellatrix LLC, and is the founder and owner of Targeted Therapeutics LLC, however it has no contribution to the current study. Other authors state no conflicts of interest.